Rothenburg J, Rink-Baron, S, Mueller L, Ostermann PN, Fischer J, Hermsen D, Stegbauer J, Moldenhauer A. Immunadsorption as a method of antibody donation during the COVID-19 pandemic. Vox sanguinis, first published May 13, 2024, https://doi.org/10.1111/vox.13647
Rothenburg J, Rink-Baron, S, Mueller L, Ostermann PN, Fischer J, Stegbauer J, Moldenhauer A. COVID-19 antibody donation using immunoadsorption: report of two cases. Transfusion and Apheresis Science, 2021, 60(5): 1-3. DOI: https://doi.org/10.1016/j.transci.2021.103193.
Derfuss T, Parikh K, Velhin S, Braun M, Mathey E, Krumbholz M, Kümpfel T, Moldenhauer A, Rader C, Sonderegger P, Pöllmann W, Tiefenthaller C, Bauer J, Lassmann H, Wekerle H, Karagogeos D, Hohlfeld R, Linington C, Meinl E. Contactin-2/Tag-1 directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proceedings of the National Academy of Sciences of the United States of America (PNAS). 2009, 106(20): 8302-8307. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals - PMC
Mathey EK, Derfuss, Storch MK, Williams KR, Hales K, Woolley DR, Al-Hayani A, Davies SN, Rasband MN, Olsson T, Moldenhauer A, Velhin S, Hohlfeld R, Meinl E, Linington C. Neurofascin as a novel target for autoantibody-mediated axonal injury. Journal of Experimental Medicine. 2007, 204:2363-2372. Neurofascin as a novel target for autoantibody-mediated axonal injury - PMC
